Research
Hormonal
Tirzepatide helps lower blood sugar levels in patients with type 2 diabetes mellitus.
Tirzepatide can be considered for managing blood sugar levels in type 2 diabetes.
StrongSupportsmedium confidence
It stimulates insulin secretion from the pancreas and helps lower blood sugar levels in patients with type 2 diabetes mellitus.
Why this rating
The claim is based on established pharmacological effects.
Source
Vitreous hemorrhage in a patient on tirzepatide: Coincidence or drug induced?
Sitara Azeem et al. · Oman Journal of Ophthalmology · 2026
DOI 10.4103/ojo.ojo_437_25
case_studyCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →